MedPath

Methocarbamol

Methocarbamol Tablets USP

Approved
Approval ID

58f867fd-cad0-4bef-9bd6-9c401bda2120

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 10, 2022

Manufacturers
FDA

Golden State Medical Supply, Inc.

DUNS: 603184490

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methocarbamol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60429-118
Application NumberANDA200958
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methocarbamol
Product Specifications
Route of AdministrationORAL
Effective DateMarch 10, 2022
FDA Product Classification

INGREDIENTS (1)

METHOCARBAMOLActive
Quantity: 500 mg in 1 1
Code: 125OD7737X
Classification: ACTIB

Methocarbamol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60429-119
Application NumberANDA200958
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methocarbamol
Product Specifications
Route of AdministrationORAL
Effective DateMarch 10, 2022
FDA Product Classification

INGREDIENTS (1)

METHOCARBAMOLActive
Quantity: 750 mg in 1 1
Code: 125OD7737X
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methocarbamol - FDA Drug Approval Details